Mineralocorticoid Receptor Blockade in Chronic Kidney Disease

Publisher： Karger

E-ISSN： 1421-9735|33|1-3|119-124

ISSN： 0253-5068

Source： Blood Purification, Vol.33, Iss.1-3, 2012-01, pp. : 119-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin Receptor Blockade and Arterial Compliance in Chronic Kidney Disease: A Pilot Study

By  

American Journal of Nephrology, Vol. 25, Iss. 4, 2005-08 ,pp. : 393-399

Karger

Access to resources Recommend Favorite

Mineralocorticoid Receptor Antagonism and Aldosterone Synthesis Inhibition Do Not Improve Glomerulosclerosis and Renal Interstitial Fibrosis in a Model of Chronic Kidney Allograft Injury

By  

Kidney and Blood Pressure Research, Vol. 35, Iss. 6, 2012-08 ,pp. : 561-567

Karger

Access to resources Recommend Favorite

Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins

By  

Nephron, Vol. 137, Iss. 1, 2017-05 ,pp. : 1-7

Karger

Access to resources Recommend Favorite

Uromodulin and Chronic Kidney Disease

By  

Kidney and Blood Pressure Research, Vol. 33, Iss. 5, 2010-10 ,pp. : 393-398

Karger

Access to resources Recommend Favorite

Aging and Chronic Kidney Disease

By  

Kidney and Blood Pressure Research, Vol. 38, Iss. 1, 2014-03 ,pp. : 109-120

Karger

Access to resources Recommend Favorite